M Fakhrolmobasheri, AP Abhari… - Acta …, 2023 - pubmed.ncbi.nlm.nih.gov
Aim Recent studies have indicated that Sodium-GLucose co-Transporter 2 Inhibitors (SGLT2Is) may increase insulin sensitivity (IS); however, these results are heterogeneous …
M Fakhrolmobasheri, AP Abhari, B Manshaee… - Acta …, 2022 - europepmc.org
Aim Recent studies have indicated that Sodium-GLucose co-Transporter 2 Inhibitors (SGLT2Is) may increase insulin sensitivity (IS); however, these results are heterogeneous …
M Fakhrolmobasheri, AP Abhari… - Acta …, 2023 - search.ebscohost.com
Aim: Recent studies have indicated that Sodium–GLucose co-Transporter 2 Inhibitors (SGLT2Is) may increase insulin sensitivity (IS); however, these results are heterogeneous …